Apellis Pharmaceuticals (APLS) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to -$19.7 million.
- Apellis Pharmaceuticals' Other Gross PP&E Adjustments fell 1559.2% to -$19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.7 million, marking a year-over-year decrease of 1559.2%. This contributed to the annual value of -$54.6 million for FY2024, which is 1262.98% down from last year.
- Apellis Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$19.7 million in Q3 2025, which was down 1559.2% from -$14.6 million recorded in Q2 2025.
- Apellis Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at -$14.6 million during Q2 2025, with a 5-year trough of -$54.6 million in Q4 2024.
- Its 5-year average for Other Gross PP&E Adjustments is -$24.6 million, with a median of -$19.7 million in 2025.
- Per our database at Business Quant, Apellis Pharmaceuticals' Other Gross PP&E Adjustments tumbled by 6929.55% in 2021 and then skyrocketed by 2068.44% in 2023.
- Apellis Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$42.3 million in 2021, then fell by 14.45% to -$48.4 million in 2022, then dropped by 0.08% to -$48.5 million in 2023, then dropped by 12.63% to -$54.6 million in 2024, then surged by 63.87% to -$19.7 million in 2025.
- Its Other Gross PP&E Adjustments was -$19.7 million in Q3 2025, compared to -$14.6 million in Q2 2025 and -$15.3 million in Q1 2025.